TaqI B1/B2 and -629A/C cholesteryl ester transfer protein (CETP) gene polymorphisms and their association with CETP activity and high-density lipoprotein cholesterol levels in a Tehranian population. Part of the Tehran Lipid and Glucose Study (TLGS)

Genetics and Molecular Biology

Volumn 30, Issue 4, 2007, Pages 1039-1046

  Daneshpour, Maryam S ^a   Hedayati, Mehdi ^a   Azizi, Fereidoun ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cholesteryl ester transfer protein (CETP); Hardy Weinberg equilibrium; Linkage disequilibrium; Polymorphisms

Indexed keywords

ADENINE; CHOLESTEROL ESTER TRANSFER PROTEIN; CYTOSINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; GENE ACTIVITY; GENE AMPLIFICATION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HIGH RISK POPULATION; HOMOZYGOSITY; HUMAN; INTRON; IRAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL SIGNIFICANCE;

NICOTIANA TABACUM;

EID: 37649014780     PISSN: 14154757     EISSN: 16784685     Source Type: Journal    
DOI: 10.1590/S1415-47572007000600001     Document Type: Article

References (32)

1. Agellon LB, Quinet EM, Gillette TG, Drayna DT, Brown ML and Tall AR (1990) Organization of the human cholesteryl ester transfer protein gene. Biochem 29:1372-1376.
2. Assmann G, Schulte H, Oberwitter W and Hause WH (1986) New aspects in the prediction of coronary artery disease: The prospective cardiovascular munster study. In: Fidge NH and Nestel PJ (eds) Atherosclerosis VII. Elsevier Science Publishers, Amsterdam, pp 19-24.
3. Azizi F, Rahmani M and Majid M (2000) Tehran lipid and glucose study (TLGS): Rationale and design. CVD Prevention 3:50-53.
4. Azizi F, Rahmani M, Ghanbarian A, Emami H, Salehi P, Mirmiran P and Sarbazi N (2003a) A serum lipid level in an Iranian adult's population: Tehran lipid and glucose study. Eur J Epidemiol 18:311-319.
5. Azizi F, Salehi P, Etemadi A and Zahedi-Asl S (2003b) Prevalence of metabolic syndrome in an urban population: Tehran lipid and glucose study. Diabetes Res Clin Pract 61:29-37.
6. Brown ML, Inazu A, Hesler CB, Agellon LB, Mann C, Whitlock ME, Marcel YL, Milne RW, Koizumi J, Mabuchi H, et al. (1989) Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature 342:448-451.
7. Bruce C and Tall AR (1995) Cholesteryl ester transfer proteins, reverses cholesterol transport, and arteriosclerosis. Curr Opin Lipidol 6:306-311.
8. Corbex M, Poirier O, Fumeron F, Betoulle D, Evans A, Ruidavets JB, Arveiler D, LucG, Tiret L and Cambien F (2000) Extensive association analysis between the CETP gene phenotypes reveals several putative functional polymorphisms and gene-environment interaction. Genet Epidemiol 19:64-80.
9. Dachet C, Poirier O, Cambien F, Chapman J and Rouis M (2000) New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: Role of Sp1/Sp3 in transcriptional regulation. Arterioscler Thromb Vasc Biol 20:507-515.
10. Drayna D and Lawn R (1987) Multiple RFLPs at the human cholesteryl ester transfer protein (CETP) locus. Nucleic Acids Res 15:4698.
11. Fielding CJ and Fielding PE (1995) Molecular physiology of reverse cholesterol transport. J Lipid Res 36:211-228.
12. Francene V, Ronald P, Jane-dirk B, Tjeerd P and Arie T (2003) Common cholestryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy type 2 diabetes. Diabets care 26:1216-1223.
13. Freeman DJ, Griffin BA, Holmes AP, Lindsay GM, Gaffney D, Packard CJ and Shepherd J (1994) Regulation of plasma HDL-C and subfraction distribution by genetic and environmental factors: Associations between the TaqI B RFLP in the CETP gene and smoking and obesity. Arterioscler Thromb 14:336-344.
14. Friedewald WT, Levy RI and Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 18:499-502.
15. Fumeron F, Betoulle D, Luc G, Behague I, Ricard S, Poirier O, Jemaa R, Evans A, Arveiler D, Marques-Vidal P, et al. (1995) Related articles, alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest 96:1664-1671.
16. Gordon T, Castelli WP, Hjortland MC, Kannel WB and Dawber TR (1977) High-density lipoprotein as a protective factor against coronary heart disease: The Framingham heart study. Am J Med 62:707-714.
17. Heiss G, Tamir I, Davis CE, Tyroler HA, Rifkand BM, Schonfeld G, Jacobs D and Frantz Jr ID (1980) Related articles, lipoprotein-cholesterol distributions in selected North American populations: The lipid research clinics program prevalence study. Circulation 61:302-315.
18. Hirano K, Yamashita S, Kuga Y, Sakai N, Nozaki S, Kihara S, Arai T, Yanagi T, Takami S, Menju M, et al. (1995) Atherosclerotic disease in marked hyperalphalipoproteinemia. Arterioscler Thromb Vasc Biol 15:1849-1856.
19. Hsu. LA, Ko YL, Hsu KH, Ko YH and Lee YS (2002) Genetic variations in the cholesteryl ester transfer protein gene and high density lipoprotein cholesterol levels in Taiwanese Chinese. Hum Genet 110:57-63.
20. Inazu A, Brown ML, Hesler CB, Agellon LB, Koizurni J, Takata K, Maruhama Y, Mabuchi H and Tall AR (1990) Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med 323:1234-1238.
21. Inazu A, Brown ML, Hesler CB, Agellon LB, Koizumi J, Takata K, Maruhama Y, Mabuchi H and Tall AR (1990) Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med 323:1234-1238.
22. Kauma H, Savolainen MJ, Heikkila R, Rantala AO, Lilja M, Reunanen A and Kesaniemi YA (1996) Related articles, sex difference in the regulation of plasma high density lipoprotein cholesterol by genetic and environmental factors Hum Genet 97:156-162.
23. Kondo I, Berg K, Drayna DT and Lawn RM (1989) DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high-density lipoprotein cholesterol and apolipoprotein levels. Clin Genet 35:49-56.
24. Kuivenhoven JA, Jukema JW, Zwinderman AH, de Knijff P, McPherson R, Bruschke AV, Lie KI and Kastelein JJ (1998) The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary arteriosclerosis: The regression growth evaluation statin study group. N Engl J Med 338:86-93.
25. Miller NE, Thelle DS, Forde OH and Mjos OD (1997) The Tromso heart study: High-density lipoprotein and coronary heart disease: A prospective case-control study. Lancet 1:965-968.
26. Mitchell RJ, Earl L, Williams J, Bisucci T and Gasiamis H (1994) Polymorphisms of the gene coding for the cholesteryr ester transfer protein and plasma lipid levels in Italian and Greek migrants to Australia. Hum Biol 66:13-25.
27. Ordovas JM, Cupples A, Corella D, Otvos JD and Osgood D (2000) Association of cholesteryl ester transfer protein-TaqI polymorphism with variation in lipoprotein sub classes and coronary heart disease risk. Arterioscler Thromb Vase Biol 20:1323-1329.
28. Tall AR (1993) Plasma cholesteryl ester transfer protein. J Lipid Res 34:1255-1274.
29. Tenkanen H, Koskinen P, Kontula K, Aalto-Setala K, Manttari M, Manninen V, Runeberg SL, Taskinen MR and Elmholm C (1991) Polymorphisms of the gene encoding cholesterol ester transfer protein and serum lipoprotein levels in subjects with and without coronary heart disease. Hum Genet 87:574-578.
30. Truett GE, Walker JA, Ttuett AA, Mynatt RL, Heeger P and Warman M (2000) Preparation of PCR-quality DNA with hot sodium hydroxide and Tris (HOTSHOT). Biotechniques 29:52-54.
31. Warnick GR, Benderson J and Albers JJ (1982) Dextran sulfate-Mg21 precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 28:1379-1388.
32. Yen FT, Deckelbaum RJ, Mann CJ, Marcel YL, Milne RW and Tall AR (1989) Inhibition of cholesteryl ester transfer protein activity by monoclonal antibody: Effects on cholesteryl ester formation and neutral lipid mass transfer in human plasma. J Clin Invest 83:2018-2024.